• Decrease font size
  • Default font size
  • Increase font size
Latest News from Prosonix
Prosonix CEO David Hipkiss talks to in-Pharma PDF Print E-mail
Wednesday, 17 March 2010 00:00
David Hipkiss, CEO of Prosonix, recently spoke to in-Pharma technologist.com about the company's recent launch of its new UMAX® particle engineering technology and how it is set to revolutionise the field of respiratory medicines.  Please see http://www.in-pharmatechnologist.com/Processing-QC/Prosonix-launches-UMAX-particle-tech-for-respiratory-drugs
Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Read more...
Last Updated on Monday, 26 September 2011 22:23
 
Prosonix Attains International Quality Approval PDF Print E-mail
Friday, 26 June 2009 08:02

Prosonix (Oxford, UK) is pleased to announce that it has achieved accreditation to the Quality Management standard ISO 9001:2008 following a recent audit of business systems and procedures by independent external auditors SGS (UK) Ltd.

 

Attachments:
FileFile size
Download this file (Press Release ISO9000 26 June 2009.pdf)Press Release ISO9000 26 June 2009.pdf64 Kb
Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Read more...
Last Updated on Monday, 26 September 2011 22:23
 
Prosonix Announce The Launch Of UMAX technology PDF Print E-mail
Friday, 05 March 2010 00:00

Prosonix is pleased to announce the launch of its UMAX® technology - an acronym for Ultrasound Mediated Amorphous to Crystalline transition - which is a new disruptive particle engineering technology set to revolutionise respiratory medicine. The proprietary technology has  now been demonstrated on over 30 generic and novel drug molecules and combination products. 

Attachments:
FileFile size
Download this file (Press Release 1~ UMAX Launch March 2010.pdf)Press release UMAX Launch March 2010298 Kb
Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Read more...
Last Updated on Monday, 26 September 2011 22:24
 
Prosonix and Syrris launch SonoLab PDF Print E-mail
Tuesday, 17 March 2009 16:24

Following the announcement in December 2008 that Prosonix and Syrris (Royston, UK) entered a new marketing partnership to position Syrris as the prime channel to market for Prosonix's new SonoLabTM laboratory scale sonocrystallization and sonoprocessing equipment, the two companies are pleased to announce the launch of the proprietary

Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Last Updated on Monday, 26 September 2011 22:24
 
KTP Research Funding For Prosonix and Bath University PDF Print E-mail
Friday, 08 May 2009 17:00
Prosonix will be recruiting a high quality researcher in light of the recent announce -ment that a research grant of  £190,500 has been awarded to the Department of Pharmacy and Pharmacology and Prosonix to develop methodology and identify new processing technology for the manufacture of pharmaceutical co-crystals and binary API crystals suitable for use in inhaled and oral medicines. 
Attachments:
FileFile size
Download this file (Prosonix box ad_v2.pdf)Prosonix box ad_v2.pdf63 Kb
Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Read more...
Last Updated on Monday, 26 September 2011 22:25
 
Prosonix and Aeropharm Announce Agreement PDF Print E-mail
Friday, 19 December 2008 12:35
Prosonix Ltd (Oxford, UK) is delighted to announce a new agreement for the application of its proprietary ultrasonic particle engineering technology in the pharmaceutical industry. This new agreement has been concluded with Aeropharm (Rudolstadt, Germany) and is concerned with the development and manufacture of a new generation of "difficult-to-make" generic products.
Attachments:
FileFile size
Download this file (PROSONIX AND AEROPHARM FINAL.pdf)Prosonix & Aeropharm announcement43 Kb
Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Read more...
Last Updated on Monday, 26 September 2011 22:24
 
Pfizer Selects Prosonix Crystallization Technology PDF Print E-mail
Friday, 19 December 2008 11:47
Prosonix Ltd (Oxford, UK) is delighted to announce that Pfizer Global Manufacturing will implement Prosonix’ Prosonitron reactor and sonocrystallization process technology at Pfizer’s manufacturing facilities in Ireland.
Attachments:
FileFile size
Download this file (PROSONIX AND PFZER PRESS RELEASE FINAL 16 SEPTEMBER 2008 PR.pdf)Pfizer press release101 Kb
Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Read more...
Last Updated on Monday, 26 September 2011 22:25
 
Prosonix Featured in Pharmaceutical Technology PDF Print E-mail
Friday, 19 December 2008 11:48

Prosonix describe their latest advanced ultrasonic particle engineering developments in a feature article entitled "Power Ultrasound and the Production of Mesoscopic Particles and Aqueous Dispersions". For full details visit www.pharmtech.com, or read the special supplement pages s28-s35 accompanying the September 2008, Volume 32, 9 edition of Pharmaceutical Technology.

http://pharmtech.findpharma.com/pharmtech/Article/Power-Ultrasound-and-the-Production-of-Mesoscopic-/ArticleStandard/Article/detail/548822

Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Last Updated on Monday, 26 September 2011 22:25
 
Prosonix & Syrris in Marketing Partnership PDF Print E-mail
Friday, 19 December 2008 11:45

Prosonix Ltd (Oxford, UK) and Syrris (Royston, UK) are delighted to announce a new marketing partnership which positions Syrris as the prime channel to market for Prosonix’s new SonoLabTM laboratory scale sonocrystallization and sonoprocessing equipment.

 

Attachments:
FileFile size
Download this file (syrris PR.pdf)Syrris & Prosonix agreement120 Kb
Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Read more...
Last Updated on Monday, 26 September 2011 22:26
 
New SonoLab Development Suite Launched PDF Print E-mail
Friday, 19 December 2008 12:35
Sonolab-250-systemProsonix Launch New SonoLabTM Laboratory Scale Sonocrystallization Development Suite at CPHI Worldwide 2007 As part of the drive to make commercially viable sonocrystallization solutions easily accessible to the research and development activities, Prosonix [Oxford, UK] have launched a suite of manual, semi-automated, and fully automated sonocrystallization equipment. Sonocrystallizreadation technology allows chemists to control particle size, morphology and polymorphs.
Translate from en to arTranslate from en to zh-CNTranslate from en to zh-TWTranslate from en to nlTranslate from en to frTranslate from en to deTranslate from en to elTranslate from en to itTranslate from en to jaTranslate from en to koTranslate from en to pt-PTTranslate from en to ruTranslate from en to es
Read more...
Last Updated on Saturday, 17 January 2009 23:39
 
More Articles...
<< Start < Prev 1 2 3 Next > End >>

Page 2 of 3

Navigation

Home
Product Pipeline
PSX1001
PSX1002
PSX2000 Series
Partners
Pharmaceuticals
Inhalation
Combination Therapy
Market Opportunity
Technology
UMAX
SAX™
Sonocrystallization
DISCUS™
Ultrasonic Particle Rounding
CrystalGEM™
Intellectual Property
FDA Quality by Design
About Us
Board of Directors
Management Team
Collaborations
Investors
News
Events
Contact
How to find us
 
 

Latest News

03 Feb 2012 - Geoff Down appointed as Chief Medical Officer
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
More in: Latest

Events

Respiratory Drug Delivery 2012
10 October 2011 08:57
article thumbnai